WS13.5 Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlled-inhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis
作者
A.J. van Velzen,Aukje C. Bos,Daan J. Touw,Harm A.W.M. Tiddens,Harry Heijerman,Hettie M. Janssens